Baxter International Inc (BAX) stock
BAXNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 9/306% above fair value
$26.16+0.40 (+1.55%)
Close on Nov 18, 2026Market cap $13.53BP/E –Yield 1.99%
Baxter International revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Baxter International's revenue for the twelve months ending Sep 30, 2026 was $11.61B, up 5.3% year over year. For fiscal 2025 it was $11.24B, up 5.7% from the year before. Over ten years it grew 1.2% a year on average. The highest annual figure on record is $13.94B in fiscal 2012.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $11.24B | +5.7% |
| FY2024 | Dec 31, 2024 | $10.64B | +2.7% |
| FY2023 | Dec 31, 2023 | $10.36B | +3.0% |
| FY2022 | Dec 31, 2022 | $10.06B | -17.2% |
| FY2021 | Dec 31, 2021 | $12.15B | +4.1% |
| FY2020 | Dec 31, 2020 | $11.67B | +2.7% |
| FY2019 | Dec 31, 2019 | $11.36B | +2.4% |
| FY2018 | Dec 31, 2018 | $11.10B | +4.9% |
| FY2017 | Dec 31, 2017 | $10.58B | +4.1% |
| FY2016 | Dec 31, 2016 | $10.16B | +2.0% |
| FY2015 | Dec 31, 2015 | $9.97B | -7.0% |
| FY2014 | Dec 31, 2014 | $10.72B | +13.9% |
| FY2013 | Dec 31, 2013 | $9.41B | -32.5% |
| FY2012 | Dec 31, 2012 | $13.94B | +0.3% |
| FY2011 | Dec 31, 2011 | $13.89B | +8.2% |
| FY2010 | Dec 31, 2010 | $12.84B | +2.2% |
| FY2009 | Dec 31, 2009 | $12.56B | +1.7% |
| FY2008 | Dec 31, 2008 | $12.35B | +9.6% |
| FY2007 | Dec 31, 2007 | $11.26B | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $2.98B | +5.0% |
| Q2 FY2026 | Jun 30, 2026 | $2.96B | +5.3% |
| Q1 FY2026 | Mar 31, 2026 | $2.70B | +2.9% |
| Q4 FY2025 | Dec 31, 2025 | $2.97B | +8.0% |
| Q3 FY2025 | Sep 30, 2025 | $2.84B | +5.0% |
| Q2 FY2025 | Jun 30, 2025 | $2.81B | +4.3% |
| Q1 FY2025 | Mar 31, 2025 | $2.63B | +5.4% |
| Q4 FY2024 | Dec 31, 2024 | $2.75B | +0.9% |
| Q3 FY2024 | Sep 30, 2024 | $2.70B | +3.8% |
| Q2 FY2024 | Jun 30, 2024 | $2.69B | +4.0% |
| Q1 FY2024 | Mar 31, 2024 | $2.49B | +2.0% |
| Q4 FY2023 | Dec 31, 2023 | $2.73B | -27.1% |
| Q3 FY2023 | Sep 30, 2023 | $2.60B | -28.0% |
| Q2 FY2023 | Jun 30, 2023 | $2.59B | -27.9% |
| Q1 FY2023 | Mar 31, 2023 | $2.44B | -31.4% |
| Q4 FY2022 | Dec 31, 2022 | $3.75B | +30.2% |
| Q3 FY2022 | Sep 30, 2022 | $3.61B | +11.9% |
| Q2 FY2022 | Jun 30, 2022 | $3.59B | +16.0% |
| Q1 FY2022 | Mar 31, 2022 | $3.56B | +20.8% |
| Q4 FY2021 | Dec 31, 2021 | $2.88B | -9.6% |
| Q3 FY2021 | Sep 30, 2021 | $3.23B | +8.5% |
| Q2 FY2021 | Jun 30, 2021 | $3.10B | +14.0% |
| Q1 FY2021 | Mar 31, 2021 | $2.95B | +5.1% |
| Q4 FY2020 | Dec 31, 2020 | $3.18B | +4.7% |
| Q3 FY2020 | Sep 30, 2020 | $2.97B | +4.2% |
| Q2 FY2020 | Jun 30, 2020 | $2.72B | -4.1% |
| Q1 FY2020 | Mar 31, 2020 | $2.80B | +6.2% |
| Q4 FY2019 | Dec 31, 2019 | $3.04B | +7.3% |
| Q3 FY2019 | Sep 30, 2019 | $2.85B | +3.3% |
| Q2 FY2019 | Jun 30, 2019 | $2.83B | +0.7% |
| Q1 FY2019 | Mar 31, 2019 | $2.64B | -2.0% |
| Q4 FY2018 | Dec 31, 2018 | $2.83B | +2.1% |
| Q3 FY2018 | Sep 30, 2018 | $2.76B | +2.0% |
| Q2 FY2018 | Jun 30, 2018 | $2.81B | +8.0% |
| Q1 FY2018 | Mar 31, 2018 | $2.69B | +8.8% |
| Q4 FY2017 | Dec 31, 2017 | $2.77B | +4.9% |
| Q3 FY2017 | Sep 30, 2017 | $2.71B | – |
| Q2 FY2017 | Jun 30, 2017 | $2.61B | – |
| Q1 FY2017 | Mar 31, 2017 | $2.48B | – |
| Q4 FY2016 | Dec 31, 2016 | $2.65B | – |
See a number that looks wrong?